A trove of new documents finally made public show that Bayer did not report a significant number of the reports of injuries it received over its Essure contraceptive device. Touted as a safe alternative to surgical sterilization, Essure would, instead, leave tens of thousands of women with intense bleeding and unbearable pain.
A legal maneuver by advocacy group Public Justice led to the release of the information. The hundreds of ...
continue reading...
The device caused such an outrage in countries around the world that Bayer removed it from the market. However, despite thousands of reports of injury and tens of thousands of women lobbying to have it pulled from US shelves, Essure is still available in the United States.
Injuries continue to mount as a result. In the meantime, a plaintiff in a previous Essure injury case; Jessica Williams ...
continue reading...Acknowledging a global decline in demand for its Essure contraceptive device, Bayer announced last week that it was pulling the device off the market around the world – except for the United States. In the same statement, the medical manufacturing giant sought to assure the public that the decision was “not linked to a safety or product quality problem.”
Tens of thousands of women in the ...
continue reading...One of the key components of Bayer’s Essure defense has been to shift blame for injuries away from itself and onto other entities. However, with the latest decision by Alameda County Superior Court Judge Winifred Y. Smith, the pharmaceutical company’s ability to do that has become seriously impaired.
Federal preemption invalidates any state law that runs contrary to federal law. Put simply, it says that the law of the ...
continue reading...
A study conducted by researchers at Northwestern University has concluded that the FDA has largely failed in its responsibility of protecting women from faulty or poorly designed medical devices.
Of the 18 devices approved between 2000 and 2015 for high risk application to women’s medical care; including fetal monitoring, contraception, and uterine bleeding:
A federal judge in Philadelphia has determined that an Essure lawsuit filed against pharmaceutical giant Bayer has enough merit to proceed. Bayer had previously moved for the case to be dismissed.
The judge sided with Bayer on most of its motion. The plaintiffs had originally brought 12 claims against the company and, using an FDA provision specific to devices granted premarket approval, Bayer argued that Essure was effectively protected from any ...
continue reading...
